InsidersTradesSigma
Track the 醫揚 stock price and the full insider trade history of the company, a listed equity based in Taiwan. Shares are quoted on TW TW, under the oversight of TWSE / TPEx (MOPS). Market capitalisation: €4.1bn. The latest transaction was reported on 8 June 2026 (Negotiated). Among the most active insiders: 莊富鈞. Every trade is openly available.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
醫揚 is a company listed on the XTAI market, specializing in the healthcare sector.